• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Ally Bridge Group

Imperative Care raises $85m

December 10, 2019 By Nancy Crotti

Neurovascular device company Imperative Care (Campbell, Calif.) said today that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of its portfolio. The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing investors Ascension Ventures, Delos Capital, Rock Springs […]

Filed Under: Blog Tagged With: 3H Health Investment, Ally Bridge Group, Ascension Health Ventures, Bain Capital, deloscapital, Imperative Care, Incept, rock springs capital

Venclose closes $27m Series C

December 4, 2019 By Sean Whooley

Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Funding Roundup, News Well, Vascular Tagged With: Ally Bridge Group, venclose

5 medtech stories we missed this week: Jan. 26, 2018

January 26, 2018 By Danielle Kirsh

From Attune Medical receiving FDA 510(k) clearance to Synapse Medical having CE Mark approval, here are 5 medtech stories we missed this week but thought were still worth mentioning. 1. Attune Medical gets FDA 510(k) clearance Attune Medical announced in a Jan. 8 press release that it has received FDA 510(k) clearance for its EnsoETM […]

Filed Under: 510(k), Food & Drug Administration (FDA), Hospital Care, Neuromodulation/Neurostimulation, Regulatory/Compliance, Respiratory Tagged With: Ally Bridge Group, Attune Medical, Axonics Modulation Technologies, LifeTech Scientific Corp., MedTech, ResMed Inc., Synapse Biomedical Inc.

Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014

December 5, 2014 By MassDevice Contributors Network Leave a Comment

TAVI: Direct Flow Medical raises $32m, names 1st CCO

December 3, 2014 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Covidien, Deerfield Management, Direct Flow Medical Inc., Kurma Partners, Life Sciences Partners, PDL BioPharma, Sightline Partners, Spray Fund, SV Life Sciences, VI Partners, Xeltis

Conventus Orthopaedics raises $24m for arm fracture implants

December 2, 2014 By Brad Perriello Leave a Comment

Conventus Orthopedics raises $24m for arm fracture implant

Conventus Orthopaedics said it closed a Series AA round worth $24 million it plans to use to commercialize 1of its self-expanding extremities implants and advance R&D on another.

Filed Under: Funding Roundup, News Well, Orthopedics Tagged With: Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Deerfield Management, Extremities, Sightline Partners, Spray Fund, Venture Capital/Private Equity

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy